Cargando…
Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
In some cases of breast cancer, diagnosis of triple‐negative breast cancer (TNBC) requires further fluorescence in situ hybridization (FISH) for determining human epidermal growth factor receptor 2 (HER2) status. However, few cases undergo FISH in China, leading to difficulty regarding subsequent tr...
Autores principales: | Wang, Chao‐Qun, Tang, Chih‐Hsin, Chang, Hao‐Teng, Li, Xiao‐Ni, Zhao, Yong‐Ming, Su, Chen‐Ming, Hu, Gui‐Nv, Zhang, Tao, Sun, Xin‐Xin, Zeng, Yue, Du, Zhang, Wang, Yan, Huang, Bi‐Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971926/ https://www.ncbi.nlm.nih.gov/pubmed/27184764 http://dx.doi.org/10.1002/cam4.746 |
Ejemplares similares
-
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017) -
High Expression of Both Resistin and Fascin-1 Predicts a Poor Prognosis in Patients with Colorectal Cancer
por: Wang, Chao-Qun, et al.
Publicado: (2020) -
Nuclear fascin regulates cancer cell survival
por: Lawson, Campbell D, et al.
Publicado: (2022) -
Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021) -
The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)